Antigenic peptide nanofibers elicit adjuvant-free CD8+ T cell responses

Vaccine

Volumn 32, Issue 10, 2014, Pages 1174-1180

  Chesson, Charles B ^a   Huelsmann, Erica J ^b   Lacek, Andrew T ^b   Kohlhapp, Frederick J ^c   Webb, Matthew F ^b   Nabatiyan, Arman ^b   Zloza, Andrew ^b   Rudra, Jai S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adjuvant; CD8+ T cell; Nanofiber; Peptide; Self assembly; Vaccine

Indexed keywords

ADJUVANT; CD8(+) T CELL; NANOFIBER; PEPTIDE; SELF-ASSEMBLY; VACCINE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NANOFIBERS; ORTHOMYXOVIRIDAE INFECTIONS; OVALBUMIN; PEPTIDES;

EID: 84893927702     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.11.047     Document Type: Article

References (26)

1. O'Hagan D.T., Valiante N.M. Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov 2003, 2(9):727-735.
2. Black M., Trent A., Tirrell M., Olive C. Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists. Expert Rev Vaccines 2010, 9(2):157-173.
3. McKee A.S., MacLeod M.K., Kappler J.W., Marrack P. Immune mechanisms of protection: can adjuvants rise to the challenge?. BMC Biol 2010, 8:37.
4. + T cell priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity. J Immunol 2007, 179(8):5033-5040.
5. Rosenberg S.A., Yang J.C., Restifo N.P. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004, 10(9):909-915.
6. Aichele P., Brduscha-Riem K., Zinkernagel, Hengartner R.M., H Pircher H. T cell priming versus T cell tolerance induced by synthetic peptides. J Exp Med 1995, 182(1):261-266.
7. Toes R.E.M., Offringa R., Blom R.J.J., Melief C.J.M., Kast W.M. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction. Proc Natl Acad Sci USA 1996, 93(15):7855-7860.
8. + T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation. J Exp Med 2003, 197(6):751-762.
9. + T cell sequestration, dysfunction and deletion. Nat Med 2013, 19(4):465-472.
10. Rudra J.S., Tian Y.F., Jung J.P., Collier J.H. A self-assembling peptide acting as an immune adjuvant. Proc Natl Acad Sci USA 2010, 107(2):622-627.
11. Rudra J.S., Sun T., Bird K.C., Daniels M.D., Gasiorowski J.Z., Chong A.S., et al. Modulating adaptive immune responses to peptide self-assemblies. ACS Nano 2012, 6(2):1557-1564.
12. Rudra J.S., Mishra S., Chong A.S., Mitchell R.A., Nardin E.H., Nussenzweig V., et al. Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope. Biomaterials 2012, 33(27):6476-6484.
13. Huang Z.H., Shi L., Ma J.W., Sun Z.Y., Cai H., Chen Y.X., et al. A totally synthetic, self-assembling, adjuvant-free MUC1 glycopeptide vaccine for cancer therapy. J Am Chem Soc 2012, 134(21):8730-8733.
14. Huebener N., Lange B., Lemmel C., Rammensee H.G., Strandsby A., Wenkel J., et al. Vaccination with minigenes encoding for novel 'self' antigens are effective in DNA-vaccination against neuroblastoma. Cancer Lett 2003, 197(1-2):211-217.
15. Kohlhapp F.J., Zloza A., O'Sullivan J.A., Moore T.V., Lacek A.T., Jagoda M.C., et al. CD8(+) T cells sabotage their own memory potential through IFN-γ -dependent modification of the IL-12/IL-15 receptor α axis on dendritic cells. J Immunol 2012, 188(8):3639-3647.
16. + T cells and autoimmune vitiligo. Autoimmunity 2011, 44(8):599-606.
17. + T cell memory recall but not effector responses. Nat Med 2012, 18(3):422-428.
18. + T cell epitopes of ovalbumin. J Biomed Biotechnol 2011, 497364.
19. + T cell recruitment and proliferation during influenza infection. Virology 2005, 340(2):296-306.
20. + T cell immunodominance hierarchies when antigen is limiting. J Immunol 2006, 177(5):2917-2925.
21. + T cells induces psoriasis. Am J Pathol 1999, 155(1):145-158.
22. Zaiss D.M., Boog C.J., van Eden W., Sijts A.J. Considerations in the design of vaccines that induce CD8 T cell mediated immunity. Vaccine 2010, 28(49):7716-7722.
23. + T cells favor rapid memory differentiation and preservation of proliferative potential upon boosting. Immunity 2013, 39:171-183.
24. + T cells to be activated by residual antigen. J Exp Med 2010, 207(6):1153-1160.
25. Knuf M., Kowalzik F., Kieninger D. Comparative effects of carrier proteins on vaccine-induced immune response. Vaccine 2011, 29(31):4881-4890.
26. Hudalla G.A., Modica J.A., Tian Y.F., Rudra J.S., Chong A.S., Sun T., et al. A self-adjuvanting supramolecular vaccine carrying a folded protein antigen. Adv Healthcare Mater 2013, 2(8):1114-1119.